Probing the Pathogenesis of North American Indian Childhood Cirrhosis (NAIC)
Probing the Pathogenesis of North American Indian Childhood Cirrhosis (NAIC)
批准号:
9235141
负责人:
Samuel Brady Sondalle
金额:
$2.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-01 至 2018-03-31
关键词:
Animal ModelBiliaryBiliary cirrhosisBiogenesisC-terminalCell Culture TechniquesCell LineCell NucleolusCellsChildhoodCirrhosisCritical ThinkingDataDefectDevelopmentDiseaseDisease modelEducationFunctional disorderGastrointestinal tract structureGenetic TranscriptionGleanGoalsHela CellsHepatocyteHereditary DiseaseHigh Fat DietHumanInvestigationLaboratoriesLifeLiverLiver diseasesMalignant NeoplasmsMapsMessenger RNAMetabolicModelingMolecularMutationNeonatal JaundiceNorth American IndiansNucleolar ProteinsObesityOrganismPathogenesisPatientsPhenotypePhysiciansPlant RootsPopulationPrimary biliary cirrhosisProcessProteinsRare DiseasesResearchResearch PersonnelRibonucleoproteinsRibosomal RNARibosomesRoleScientistStressTP53 geneTestingWhole OrganismWorkXenopusYeastsanalogbiological adaptation to stresscareerdisease phenotypeeffective therapyhuman diseaseinnovationinsightknock-downliver developmentliver transplantationmembermutantneonatal transient jaundicenovelprotein functionprotein protein interactionpublic health relevancerRNA Precursorskills
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Ribosome biogenesis is a fundamental and energy intensive process for any growing or metabolically active cells. Complete loss of this process is incompatible with life. However, defects in ribosome biogenesis have been associated with a range of maladies including cancer and developmental diseases, termed ribosomopathies. One putative ribosomopathy with liver-specific defects is North American Indian Childhood Cirrhosis (NAIC), characterized by transient neonatal jaundice progressing to biliary cirrhosis. The only effective treatment is liver transplantation. Patients with this disease have an R565W mutation in the C-terminal region of human UTP4/Cirhin (hUTP4/Cirhin), a member of the t-UTP/UTPA subcomplex of the SSU processome, both of which are required for pre-rRNA transcription and processing. Our laboratory has previously shown that the C-terminus of hUTP4/Cirhin interacts with a novel, metazoan- specific ribosome biogenesis factor called NOL11. The R565W mutation disrupts the interaction between hUTP4/Cirhin and NOL11 leading us to hypothesize that the pathogenesis of NAIC is due to nucleolar dysfunction. SPECIFIC AIMS: The first aim will test the hypothesis that defective pre-rRNA processing contributes to the pathogenesis of NAIC. I will examine the effects of the R565W mutation on human pre- rRNA processing in cell culture and test the effect of the R565W mutation on protein-protein interactions within the t-UTP/UTPA subcomplex and SSU processome. As a complete understanding of all the t-UTP/UTPA subcomplex members is necessary for dissecting the pathogenesis of NAIC, I propose to discover the final unidentified human t-UTP/UTPA subcomplex analog of yeast Utp9. The nucleolar stress response is implicated in many other ribosomopathies. Therefore, I will test the hypothesis that the R565W mutation results in p53 induction. Since NAIC is a congenital disease, in the second aim I will establish Xenopus tropicalis as a model for the disease, allowing for the study of its pathogenesis within the context of a developing organism.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Ribosomes Need Straight A's to Sleep.
核糖体需要直 A 才能休眠。
DOI:
10.1016/j.cell.2017.04.019
发表时间:
2017
期刊:
Cell
影响因子:
64.5
作者:
[Sondalle,SamuelB, Baserga,SusanJ]
通讯作者:
Baserga,SusanJ
The pre-rRNA processing factor DEF is rate limiting for the pathogenesis of MYCN-driven neuroblastoma.
rRNA前体加工因子DEF是MYCN驱动的神经母细胞瘤发病机制的速率限制
DOI:
10.1038/onc.2016.527
发表时间:
2017-07-06
期刊:
Oncogene
影响因子:
8
作者:
[Tao T, Sondalle SB, Shi H, Zhu S, Perez-Atayde AR, Peng J, Baserga SJ, Look AT]
通讯作者:
Look AT
Probing the Pathogenesis of North American Indian Childhood Cirrhosis (NAIC)
-
批准号:9121276
-
项目类别:
-
资助金额:$2.82万
-
财政年份:2016
-
负责人:Samuel Brady Sondalle
-
依托单位:
海外基金